Quality of Life after Deep Brain Stimulation in Parkinson's Disease: Does the Target Matter?
Movement Disorders Clinical Practice · 2024-11 · 11 (11) · 1379-1387
DOI: 10.1002/mdc3.14199 ↗Kurz gefasst
Fachartikel in der Zeitschrift Movement Disorders Clinical Practice, online erschienen am 03.09.2024. Verfasst von Sandra Murcia Carretero und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Bern University Hospital and University of Bern, Bern, Switzerland. Hauptthemen laut MEDLINE: Deep Brain Stimulation, Parkinson Disease, Quality of Life, Subthalamic Nucleus. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Deep brain stimulation (DBS) of the subthalamic nucleus (STN) and globus pallidus internus (GPi) is an accepted therapy for Parkinson's disease (PD) with disabling motor complications. For elderly patients with poorer cognition and postural instability, GPi has been proposed as the preferable DBS target based on expert opinion, arguing GPi‐DBS may be less complicated by depression, apathy, worsened verbal fluency, and executive dysfunction, resulting in greater improvement in quality of life (QoL). However, data supporting such patient‐tailored approach are lacking.
Objectives
The aims were to analyze whether the DBS target influences QoL in a PD cohort and a matched subgroup of frail patients with poor cognitive status and reduced postural stability, and whether other factors affect the QoL outcomes.
Methods
In this retrospective study, we analyzed a single‐center cohort of 138 PD patients who received bilateral STN‐DBS (117) or GPi‐DBS (21) using the mentioned approach for target selection. All patients underwent standardized clinical evaluations of motor‐ and nonmotor signs as well as QoL before and 1 year after surgery.
Results
DBS of both targets improved motor signs, dyskinesias, and pain. QoL improved without significant difference between the targets, but with a trend for greater improvement across all QoL domains in favor of the STN, even in an STN subgroup matched to the GPi group.
Conclusion
Our results contradict the prevailing belief that GPi‐DBS is superior in frail PD patients with cognitive decline and postural instability, questioning the proposed patient‐tailored approach of DBS target selection. Further studies are needed for a data‐driven approach.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Neurology, Bern University Hospital and University of Bern, Bern, Switzerland.
- Graduate School for Health Sciences, University of Bern, Bern, Switzerland.
- Department of Neurosurgery, Bern University Hospital and University of Bern, Bern, Switzerland.
- Institute of Neurology, Konolfingen, Switzerland.
ORCID-Profile: Ines Debove, Deborah Amstutz, Martin Lenard Lachenmayer
Zitieren
APA
Murcia Carretero, S., Petermann, K., Debove, I., Amstutz, D., Sousa, M., Waskönig, J., Diamantaras, A. A., Tinkhauser, G., Nowacki, A., Pollo, C., Schuepbach, M., Krack, P., & Lachenmayer, M. L. (2024). Quality of Life after Deep Brain Stimulation in Parkinson's Disease: Does the Target Matter?. Movement Disorders Clinical Practice, 11(11), 1379-1387. https://doi.org/10.1002/mdc3.14199
Vancouver
Murcia Carretero S, Petermann K, Debove I, Amstutz D, Sousa M, Waskönig J, et al. Quality of Life after Deep Brain Stimulation in Parkinson's Disease: Does the Target Matter?. Movement Disorders Clinical Practice. 2024;11(11):1379-1387. doi:10.1002/mdc3.14199
BibTeX
@article{MurciaCarretero2024,
author = {Murcia Carretero, Sandra and Petermann, Katrin and Debove, Ines and Amstutz, Deborah and Sousa, Mário and Waskönig, Julia and Diamantaras, Andreas Antonios and Tinkhauser, Gerd and Nowacki, Andreas and Pollo, Claudio and Schuepbach, Michael and Krack, Paul and Lachenmayer, Martin Lenard},
title = {Quality of Life after Deep Brain Stimulation in Parkinson's Disease: Does the Target Matter?},
journal = {Movement Disorders Clinical Practice},
year = {2024},
volume = {11},
number = {11},
pages = {1379--1387},
doi = {10.1002/mdc3.14199}
}
EUVIMED